Parent-Child EF Intervention
Koronis Biomedical Technologies · with University of Minnesota, National Institute of Mental Health (NIMH) · NCT06924307
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 2–5 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 140
- US sites recruiting
- 1
- Study start
- March 10, 2025
- Record last updated
- April 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Koronis Biomedical Technologies Corporation (KBT) is developing a cognitive intervention to promote healthy development of Executive Function (EF) skills in young children by leveraging a smartphone-based training regime designed for parents.
Being studied: Executive Function Intervention
Conditions: Cognitive Intervention to Promote Healthy Development of Executive Function (EF) Skills in Young Children
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Children ages 2-5 years.
- Caregivers/guardian of the participating child.
Exclusion Criteria
- Children with physical disabilities affecting vision, hearing, or basic mobility.
- Children with severe developmental delays or disorders
- Parents or caregivers who cannot read and understand English
Recruiting US locations
University of Minnesota, Institute of Child Development
Minneapolis, MN 55455
Site contact: Stephanie M. Carlson, PhD · 612-626-3187 · smc@umn.edu
Study contacts (from the official record)
- Stephanie M. Carlson, PhD · 612-626-3187 · smc@umn.edu
- Shane Anderson, MS · 612-730-1091 · sanderson@koronisbiotech.com
Similar studies in Minnesota
All healthy volunteers studies in Minnesota →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Location
- Dilworth, MN + 2 other US sites
- Eligibility basics
- Ages 25–75
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75